Clinical and radiological outcome following trauma-related reverse shoulder arthroplasty
Archives of Orthopaedic and Trauma Surgery · 07.06.2024 · 144 (7) · 3103-3111
DOI: 10.1007/s00402-024-05395-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, online erschienen am 07.06.2024. Verfasst von Cornelius Sebastian Fischer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traumatology and Reconstructive Surgery, BG Unfallklinik Tübingen, Eberhard Karls University Tübingen, Schnarrenbergstraße 95, 72076, T…. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Shoulder, Shoulder Fractures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen.
Abstract (Originalsprache)
Background
Reverse shoulder arthroplasty (RSA) is a frequently used therapy for complex proximal humeral fractures and posttraumatic disorders. The present study’s purpose was to assess the clinical and radiological outcome of primary and secondary RSA, and to analyze the impact of refixation of the greater tuberosity (GT). Patients and methods 28 patients with primary fracture RSA and 18 patients with RSA due to posttraumatic disorders were examined with a mean clinical follow-up of 2.5 ± 1.73 years. Operative details and radiographs were retrospectively reviewed. Additional analyses were performed for healed and non-healed GT in primary RSA.
Results
Patients with fracture RSA had higher Constant-Murley score (CMS) than secondary RSA without reaching significance ( p = 0.104). No significant difference was present for the quality of life measured by the Short Form 36 (SF 36) and the range of motion. In primary RSA, 78.6% GT healed anatomically. Compared to non-healed GT, patients with healed GT had a significantly higher CMS ( p = 0.011), external rotation ( p = 0.026) and forward flexion ( p = 0.083), whereas DASH score was lower without a significant difference ( p = 0.268). SF 36 showed no significant difference. Patients with healed GT had a more neutral glenoid version ( p = 0.009).
Conclusion
Superior range of motion and clinical outcome scores were present for anatomically healed GT. Therefore, refixation of the tuberosities is recommended. Secondary RSA can result in inferior results compared to primary RSA, so patients need to be adequately informed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traumatology and Reconstructive Surgery, BG Unfallklinik Tübingen, Eberhard Karls University Tübingen, Schnarrenbergstraße 95, 72076, Tübingen, Germany. cfischer@bgu-tuebingen.de.
- Department of Traumatology and Reconstructive Surgery, BG Unfallklinik Tübingen, Eberhard Karls University Tübingen, Schnarrenbergstraße 95, 72076, Tübingen, Germany.
- Department of Orthopaedics and Trauma Surgery, Klinik Gut, Via Arona 34, St. Moritz, 7500, Switzerland.
Förderung
- Universitätsklinikum Tübingen
Zitieren
APA
Fischer, C. S., Lohr, C., Ziegler, P., Schüll, D., Finger, F. C., Histing, T., Herbst, M., & Hemmann, P. (2024). Clinical and radiological outcome following trauma-related reverse shoulder arthroplasty. Archives of Orthopaedic and Trauma Surgery, 144(7), 3103-3111. https://doi.org/10.1007/s00402-024-05395-2
Vancouver
Fischer CS, Lohr C, Ziegler P, Schüll D, Finger FC, Histing T, et al. Clinical and radiological outcome following trauma-related reverse shoulder arthroplasty. Archives of Orthopaedic and Trauma Surgery. 2024;144(7):3103-3111. doi:10.1007/s00402-024-05395-2
BibTeX
@article{Fischer2024,
author = {Fischer, Cornelius Sebastian and Lohr, Christian and Ziegler, Patrick and Schüll, Daniel and Finger, Felix Christioph and Histing, Tina and Herbst, Moritz and Hemmann, Philipp},
title = {Clinical and radiological outcome following trauma-related reverse shoulder arthroplasty},
journal = {Archives of Orthopaedic and Trauma Surgery},
year = {2024},
volume = {144},
number = {7},
pages = {3103--3111},
doi = {10.1007/s00402-024-05395-2}
}
EUVIMED